secwatch.observer — SEC 8-K summary
======================================

Issuer:     LISATA THERAPEUTICS, INC. (LSTA)
CIK:        0000320017
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0000320017-25-000039
Event type: other_material
Sentiment:  positive
Materiality: 0.45
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lisata extends cash runway from Q3 2026 to Q4 2026
--------------------------------------------------

- Company now expects current cash to fund operations into Q4 2026, versus prior Q3 2026 estimate.
- As of March 31, 2025, cash, cash equivalents and marketable securities were approximately $25.8 million.
- Revised guidance based on existing and planned activities; no other material changes disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/320017/000032001725000039/0000320017-25-000039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/320017/000032001725000039/clbs-20250617.htm
  HTML page:      https://secwatch.observer/filing/0000320017-25-000039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer